NCT02435134

Brief Summary

Hip internal rotation range of motion (HIRROM) assessment is performed to assess the mobility of the hip. The assessment is typically done manually (manual testing), which induces large variability in the results between and within testers. An initial version of an examination chair (EC1) was recently developed with the aim to minimize the variability of testing results for HIRROM assessments. A new version of the examination chair (EC2) has been implemented in order to individualize the testing protocol and will be validated in this study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2015

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 6, 2015

Completed
5 months until next milestone

Study Start

First participant enrolled

October 7, 2015

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 25, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 25, 2017

Completed
Last Updated

February 14, 2017

Status Verified

February 1, 2017

Enrollment Period

1.3 years

First QC Date

April 27, 2015

Last Update Submit

February 13, 2017

Conditions

Limited Hip Mobility

Outcome Measures

Primary Outcomes (1)

  • Hip internal rotation range of motion angle (degrees)

    Participants will be tested for hip internal range of motion using three different methods. The measurements will be repeated 7 days after the initial measurement.

    7 days

Study Arms (1)

Healthy participants

Other: no intervention

Interventions

no interventionOTHER
Healthy participants

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Healthy participants

You may qualify if:

  • Participants are pain free in the lower extremity, hip and back
  • Participants signed the consent form

You may not qualify if:

  • Participant requires pain relief medication
  • History of hip surgery
  • Neuromuscular disorders
  • Legal incompetence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Schulthess Klinik

Zurich, 8008, Switzerland

Location

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2015

First Posted

May 6, 2015

Study Start

October 7, 2015

Primary Completion

January 25, 2017

Study Completion

January 25, 2017

Last Updated

February 14, 2017

Record last verified: 2017-02

Locations

CH(1)